GenoME Diagnostics has just secured over €1.5 million (£1.4 million) to develop its solution for earlier and more accurate detection of ovarian cancer. The Belfast-based team now plans to expand. Spotting cancer early is critical. It means that treatment can get underway before cancer spreads and can drastically increase the chance of survival. When it…
This content is for members only. Visit the site and log in/register to read.
The post Belfast-based GenoME Diagnostics secures over €1.5 million to improve cancer diagnosis appeared first on EU-Startups.